GLP-1 And Pregnancy: Safety Guide

GLP-1 medications are not recommended during pregnancy, and women of reproductive age should understand the important steps needed to ensure safety when planning a pregnancy or if an unexpected pregnancy occurs during treatment. At Form Blends, we discuss reproductive planning with all eligible patients before starting GLP-1 therapy. This guide covers what you need to know.

Current FDA Guidance

All currently approved GLP-1 receptor agonists, including semaglutide and tirzepatide, carry labeling that advises against use during pregnancy . The medications have not been adequately studied in pregnant humans, and the available evidence is insufficient to determine whether they pose a risk of birth defects, miscarriage, or other adverse pregnancy outcomes.

Animal Study Data

In animal reproductive toxicology studies, GLP-1 receptor agonists have been associated with adverse developmental outcomes at doses comparable to or exceeding those used in humans. Findings in animal studies have included :

• Reduced fetal body weight
• Skeletal abnormalities
• Increased rate of pregnancy loss
• Delayed fetal development

While animal studies do not always predict human outcomes, these findings are concerning enough to warrant a precautionary approach. The mechanism likely relates to reduced nutrient availability to the developing fetus due to the medication's effects on appetite suppression, reduced food intake, and delayed gastric emptying .

Fertility Considerations

GLP-1 Medications May Increase Fertility

An important and sometimes unexpected consequence of GLP-1 therapy is that weight loss can increase fertility in women who were previously having difficulty conceiving. Obesity is associated with ovulatory dysfunction, and significant weight loss can restore regular ovulation .

Women with polycystic ovary syndrome (PCOS), a common condition linked to insulin resistance and obesity, may be particularly likely to experience improved fertility on GLP-1 therapy. The combination of weight loss and improved insulin sensitivity can normalize hormone levels and restore menstrual regularity .

This has led to anecdotal reports of "Ozempic babies," pregnancies that occurred unexpectedly in women who believed they were infertile or had low fertility due to weight-related hormonal issues . While this can be welcome news for women planning a family, it can also lead to unplanned pregnancies if contraception is not being used.

Contraception Considerations

GLP-1 medications delay gastric emptying, which can theoretically affect the absorption of oral contraceptive pills . While the clinical significance of this interaction has not been fully established, many prescribers recommend using a non-oral contraceptive method (such as an IUD, implant, patch, ring, or injectable) during GLP-1 therapy if preventing pregnancy is essential.

We discuss contraception with all women of reproductive age at Form Blends as part of our pre-treatment evaluation. If you rely on oral contraceptive pills, we review whether an alternative method might provide more reliable protection during your treatment .

Pre-Conception Planning

When To Stop GLP-1 Medication

Current guidance recommends discontinuing GLP-1 medications at least two months before a planned pregnancy for semaglutide, based on its pharmacokinetic properties . The recommended washout period for tirzepatide is similar. These timelines allow the medication to be substantially cleared from your body before conception.

The exact washout period should be determined in consultation with your physician, taking into account the specific medication, your dose, and your individual medical circumstances .

Working With Your Healthcare Team

If you are considering pregnancy while on or after GLP-1 therapy, we recommend:

• Informing your Form Blends physician and your OB/GYN about your plans
• Developing a timeline for medication discontinuation
• Transitioning to a weight maintenance plan that does not rely on GLP-1 medication weight regain after stopping GLP-1
• Starting prenatal vitamins, including folic acid, at least one month before attempting conception
• Establishing baseline metabolic labs (blood sugar, thyroid function, nutritional markers)

Weight Loss Before Pregnancy Can Be Beneficial

While GLP-1 medications must be stopped before pregnancy, the weight loss achieved during treatment can have lasting benefits for pregnancy outcomes. Obesity during pregnancy is associated with increased risks of :

• Gestational diabetes
• Preeclampsia (dangerously high blood pressure during pregnancy)
• Cesarean delivery
• Macrosomia (excessively large baby)
• Neural tube defects
• Stillbirth

Entering pregnancy at a lower, healthier weight can significantly reduce these risks. In this sense, GLP-1 therapy before pregnancy may actually improve pregnancy outcomes, even though the medication itself must be discontinued .

What If You Become Pregnant While Taking GLP-1 Medication

If you discover that you are pregnant while taking a GLP-1 medication:

• Stop the medication immediately and do not take your next scheduled dose
• Contact your healthcare provider as soon as possible
• Do not panic. While the medication is not recommended during pregnancy, early exposure does not necessarily mean harm has occurred. The critical period for most structural birth defects is weeks 3-8 of embryonic development
• Schedule an early prenatal visit for appropriate monitoring and reassurance
• Report the pregnancy to the medication manufacturer's pregnancy registry if one exists, as this helps gather safety data for future patients

It is worth noting that many women have had healthy pregnancies and babies after inadvertent early-pregnancy GLP-1 exposure. However, the data are limited, and close monitoring is recommended .

GLP-1 Medications After Pregnancy

After delivery, if you are not breastfeeding, GLP-1 therapy can be restarted once your physician determines it is appropriate. The timing depends on your recovery, any postpartum complications, and your weight management goals.

If you plan to breastfeed, GLP-1 medications should not be restarted until breastfeeding is complete, as discussed in our breastfeeding safety guide GLP-1 breastfeeding safety.

Gestational Diabetes And GLP-1 Medications

GLP-1 medications are not approved or recommended for the treatment of gestational diabetes . Gestational diabetes is managed with dietary modifications, exercise, and if needed, insulin therapy. Some other diabetes medications may be used during pregnancy under specific circumstances, but GLP-1 receptor agonists are not among them.

However, as noted above, GLP-1-assisted weight loss before pregnancy can reduce the risk of developing gestational diabetes in the first place GLP-1 and insulin resistance.

Special Considerations For Male Patients

Current evidence does not suggest that GLP-1 medications adversely affect male fertility or sperm quality . However, research in this area is limited. Male patients who are planning to conceive with their partner do not typically need to discontinue GLP-1 therapy based on current guidance, though individual discussions with a fertility specialist may be appropriate in certain situations .

Frequently Asked Questions

How long does semaglutide stay in my system after I stop?

Semaglutide has a half-life of approximately one week, meaning it takes about 5-7 half-lives (5-7 weeks) to be substantially eliminated from your body . This is why a two-month washout period is recommended before conception.

Can GLP-1 medications cause miscarriage?

Animal studies have shown increased pregnancy loss at some doses, but there is insufficient human data to draw definitive conclusions. The precautionary recommendation to avoid GLP-1 medications during pregnancy is based partly on this concern.

Will I gain weight back during pregnancy if I stop my GLP-1 medication?

Some weight gain during pregnancy is normal and expected. Your OB/GYN will guide you on appropriate gestational weight gain targets based on your BMI at the start of pregnancy. The focus during pregnancy shifts from weight loss to healthy weight management for both you and your baby.

Can I restart GLP-1 medication to lose pregnancy weight postpartum?

Yes, after your physician clears you and once you are no longer breastfeeding (if applicable). Many patients successfully use GLP-1 therapy for postpartum weight management. The timing of restart should be discussed with both your OB/GYN and your prescribing physician.

Should I use additional contraception beyond my oral birth control pills while on GLP-1 medication?

Given the theoretical interaction with oral contraceptive absorption, using a backup barrier method (such as condoms) or switching to a non-oral contraceptive is worth discussing with your healthcare provider, particularly during the early weeks of GLP-1 therapy when GI effects are most pronounced.

Reproductive health deserves careful planning. Form Blends includes fertility and pregnancy counseling as part of our comprehensive GLP-1 treatment program for all patients of reproductive age. Visit FormBlends.com to speak with our physician team.